Key Highlights

  • Third-quarter net sales at Nature's Sunshine Products (NASDAQ:NATR) declined 9.1% to USD 116.6 million from USD 128.3 million, or 7.2% lower when currency effects are excluded.
  • Diluted EPS landed at USD 0.11 against USD 0.30 a year earlier, as Net Income dropped 65.9% to USD 1.9 million and Operating Income fell 41.1% to USD 5.3 million.
  • China net sales decreased USD 5.5 million, a 48.8% fall that the filing links to the death of two key leaders and corrective steps involving independent consultants.
  • The company held USD 89.4 million of cash at September 30, 2026, carried no Credit Facility borrowings, and repurchased 345,000 shares for USD 6.1 million over nine months.

Sales and Profit Both Slip in the Third Quarter

A 10-Q filed on November 4, 2026 covers Nature's Sunshine Products (NASDAQ:NATR), which distributes more than 800 health and wellness items through independent consultants. Net sales of USD 116.6 million dropped 9.1% year over year, with Asia off 14.9% to USD 55.1 million and North America down 6.1% to USD 34.0 million. Europe held flat at USD 22.1 million, rising 0.9% in local currencies. Gross Margin eased to 72.9% from 73.3%, Volume incentives climbed to 32.0% of sales from 30.7%, and net income landed at USD 1.9 million versus USD 5.5 million. The effective tax rate reached 64.8% compared with 42.8%, driven by a valuation allowance on foreign tax credits, a reserve for uncertain tax positions and non-deductible executive pay.

China Disruption Offsets Mixed Results Across Asia

China is the sharpest pressure point. Sales there fell 48.8%, or 51.6% in local currency, following the loss of two senior leaders and disruptions to sales, partly due to corrective measures aimed at consultants whose conduct did not match company policy. Taiwan dropped 14.8% on weaker consumer Acquisition and fewer orders, while Japan gained 5.2% in local currency on stronger consultant activity. In the United States, sales declined 6.0% amid reduced consultant participation. The nine-month picture looks steadier: net sales were flat at USD 356.5 million, up 0.8% excluding currency, yet net income fell 33.8% to USD 10.5 million, or USD 0.59 per diluted share against USD 0.83.

Cash Location, Buyback Capacity and a Pending Trade-Controls Disclosure

Operating activities produced USD 9.7 million over nine months, down from USD 25.4 million, reflecting lower Earnings and the timing of working capital. Of the USD 89.4 million cash balance, USD 76.1 million was held in foreign markets, where Withholding taxes or repatriation limits could apply. The company bought back 345,000 shares for USD 6.1 million, leaving USD 11.3 million of authorization. A voluntary self-disclosure to the Office of Foreign Assets Control, filed after an internal trade-controls review, is still pending. The company estimates the potential violations were below 1% of net Revenue in each of the last three fiscal years and does not expect material penalties. It also cautions that tariffs could raise costs for the rest of 2026, and the filing offers no guidance.

Where Things Stand

China accounts for much of the decline. The 48.8% fall removed USD 5.5 million of quarterly sales, and Asia as a whole dropped 14.9%. Nature's Sunshine Products (NASDAQ:NATR) cushioned part of the pressure through lower selling expenses, yet operating income still fell 41.1% and the tax rate rose. Cash is solid and no credit balance is outstanding. The filing contains no guidance, consensus or price move. Watch the pace of the China recovery, US consultant engagement, the OFAC matter and Tariff effects on costs.